相关实验视频

Updated: May 10, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K

与糖溶解相关的放射敏感性特征用于预测乳腺癌中放射治疗反应

Xuan Lin1, Shiyin Hu2, Linyan Huang3

  • 1The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

Frontiers in immunology
|October 20, 2025
PubMed
概括

糖溶性活性会影响乳腺癌 (BRCA) 患者放射治疗的有效性. 一个新的四基因特征预测了反应,识别了从治疗中获益最多的患者.

关键词:
在PD-L1中.乳腺癌 乳腺癌 乳腺癌葡萄糖溶解是什么辐射敏感性 辐射敏感性瘤免疫微环境是一个微环境.

更多相关视频

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.2K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.1K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...